{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:39:53Z","timestamp":1791895193338,"version":"4.3.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T00:00:00Z","timestamp":1190073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s12016-007-8013-6","type":"journal-article","created":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T11:29:57Z","timestamp":1190028597000},"page":"85-102","source":"Crossref","is-referenced-by-count":113,"title":["Hepatitis B Virus (HBV) and Autoimmune Disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Ram","family":"Maya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,18]]},"reference":[{"issue":"5","key":"8013_CR1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1590-8658(00)80266-2","volume":"32","author":"DP Bogdanos","year":"2000","unstructured":"Bogdanos DP, Mieli-Vergani G, Vergani D (2000) Virus, liver and autoimmunity. Dig Liver Dis 32(5):440\u2013446 (June\u2013July)","journal-title":"Dig Liver Dis"},{"key":"8013_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-044452763-9\/50005-6","volume-title":"Autoantibodies","author":"S Oertelt","year":"2007","unstructured":"Oertelt S, Invernizzi P, Podda M, Gershwin ME (2007) What is an autoantibody. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds) Autoantibodies. Elsevier, Amsterdam, pp. 3\u20136"},{"issue":"1","key":"8013_CR3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","volume":"9","author":"RS Fujinami","year":"2006","unstructured":"Fujinami RS, von Herrath MG, Christen U, Whitton JL (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 9(1):80\u201394 (Jan)","journal-title":"Clin Microbiol Rev"},{"key":"8013_CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-3527(01)56008-X","volume":"56","author":"SD Miller","year":"2001","unstructured":"Miller SD, Katz-Levy Y, Neville KL, Vanderlugt CL (2001) Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler\u2019s virus infection of the central nervous system. Adv Virus Res 56:199\u2013217","journal-title":"Adv Virus Res"},{"issue":"4","key":"8013_CR5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/PL00000717","volume":"57","author":"CM Lawson","year":"2000","unstructured":"Lawson CM (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci 57(4):552\u2013560 (Apr)","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl","key":"8013_CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","volume":"25","author":"JF Bach","year":"2005","unstructured":"Bach JF (2005) Infections and autoimmune diseases. J Autoimmun 25(Suppl):74\u201380","journal-title":"J Autoimmun"},{"key":"8013_CR7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/B978-044451271-0\/50041-7","volume-title":"Infection and autoimmunity","author":"D Mimouni","year":"2004","unstructured":"Mimouni D, Pemphigus DM (2004) Infection. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 531\u2013535"},{"issue":"1","key":"8013_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2249.2006.03046.x","volume":"144","author":"TC Hsu","year":"2006","unstructured":"Hsu TC, Tsay GJ, Chen TY, Liu YC, Tzang BS (2006) Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection. Clin Exp Immunol 144(1):110\u2013116 (Apr)","journal-title":"Clin Exp Immunol"},{"key":"8013_CR9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxj009","volume":"28","author":"CW Shepard","year":"2006","unstructured":"Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28:112\u2013125","journal-title":"Epidemiol Rev"},{"issue":"Pt 6","key":"8013_CR10","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1099\/vir.0.81920-0","volume":"87","author":"A Bertoletti","year":"2006","unstructured":"Bertoletti A, Gehring AJ (2006) The immune response during hepatitis B virus infection. J Gen Virol 87(Pt 6):1439\u20131449 (Jun)","journal-title":"J Gen Virol"},{"issue":"2","key":"8013_CR11","first-page":"97","volume":"3","author":"CF Huang","year":"2006","unstructured":"Huang CF, Lin SS, Ho YC, Chen FL, Yang CC (2006) The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 3(2):97\u2013106 (Apr)","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"8013_CR12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3748\/wjg.v13.i1.82","volume":"13","author":"TF Baumert","year":"2007","unstructured":"Baumert TF, Thimme R, von Weizsacker F (2007) Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82\u201390 (Jan 7)","journal-title":"World J Gastroenterol"},{"issue":"3","key":"8013_CR13","first-page":"474","volume":"28","author":"A Csepregi","year":"2001","unstructured":"Csepregi A, Nemesanszky E, Rojkovich B, Poor G (2001) Rheumatoid arthritis and hepatitis B virus: evaluating the pathogenic link. J Rheumatol 28(3):474\u2013477 (Mar)","journal-title":"J Rheumatol"},{"issue":"1","key":"8013_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ijms.2.36","volume":"2","author":"CQ Pan","year":"2005","unstructured":"Pan CQ, Zhang JX (2005) Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci 2(1):36\u201340","journal-title":"Int J Med Sci"},{"issue":"10 Suppl","key":"8013_CR15","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/00004836-200411003-00008","volume":"38","author":"B Custer","year":"2004","unstructured":"Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV (2004) Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38(10 Suppl):S158\u2013168 (Nov\u2013Dec)","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"8013_CR16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00795-006-0328-5","volume":"39","author":"O Yokosuka","year":"2006","unstructured":"Yokosuka O, Arai M (2006) Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B. Med Mol Morphol 39(3):113\u2013120 (Sep)","journal-title":"Med Mol Morphol"},{"issue":"Suppl 1","key":"8013_CR17","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S1386-6532(06)80003-X","volume":"36","author":"JP Allain","year":"2006","unstructured":"Allain JP (2006) Epidemiology of Hepatitis B virus and genotype. J Clin Virol 36(Suppl 1):S12\u201317 (May)","journal-title":"J Clin Virol"},{"issue":"15","key":"8013_CR18","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","volume":"79","author":"SF Wieland","year":"2005","unstructured":"Wieland SF, Chisari FV (2005) Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79(15):9369\u20139380 (Aug)","journal-title":"J Virol"},{"issue":"11","key":"8013_CR19","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350(11):1118\u20131129 (Mar 11)","journal-title":"N Engl J Med"},{"issue":"2","key":"8013_CR20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2004.12.003","volume":"4","author":"Y Ichiki","year":"2005","unstructured":"Ichiki Y, He XS, Shimoda S, Ishibashi H, Keeffe EB, Rossaro L et al (2005) T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. Autoimmun Rev 4(2):82\u201395 (Feb)","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8013_CR21","first-page":"615","volume":"7","author":"BM McFarlane","year":"1995","unstructured":"McFarlane BM, Bridger CB, Smith HM, Antonov KA, Naoumov N, Williams R et al (1995) Autoimmune mechanisms in chronic hepatitis B and delta virus infections. Eur J Gastroenterol Hepatol 7(7):615\u2013621 (Jul)","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"8013_CR22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.58.10.630","volume":"58","author":"BS Tzang","year":"1999","unstructured":"Tzang BS, Chen TY, Hsu TC, Liu YC, Tsay GJ (1999) Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection. Ann Rheum Dis 58(10):630\u2013634 (Oct)","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8013_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/jaut.2000.0499","volume":"16","author":"KW Wucherpfennig","year":"2001","unstructured":"Wucherpfennig KW (2001) Structural basis of molecular mimicry. J Autoimmun 16(3):293\u2013302 (May)","journal-title":"J Autoimmun"},{"issue":"8","key":"8013_CR24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI200114235","volume":"108","author":"KW Wucherpfennig","year":"2001","unstructured":"Wucherpfennig KW (2001) Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 108(8):1097\u20131104 (Oct)","journal-title":"J Clin Invest"},{"key":"8013_CR25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2007.02.002","volume":"28","author":"A Abbas","year":"2007","unstructured":"Abbas A, Lohr J, Knoechel B (2007) Balancing autoaggressive and protective T cell responses. J Autoimmun 28:59\u201361","journal-title":"J Autoimmun"},{"issue":"5","key":"8013_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2005.12.006","volume":"5","author":"A Abou-Raya","year":"2006","unstructured":"Abou-Raya A, Abou-Raya S (2006) Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5(5):331\u2013337 (May)","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8013_CR27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2006.06.005","volume":"27","author":"B Alvarado-Sanchez","year":"2006","unstructured":"Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C et al (2006) Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27(2):110\u2013118 (Sep)","journal-title":"J Autoimmun"},{"issue":"3","key":"8013_CR28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaut.2006.08.004","volume":"27","author":"ZL Awdeh","year":"2006","unstructured":"Awdeh ZL, Yunis EJ, Audeh MJ, Fici D, Pugliese A, Larsen CE et al (2006) A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun 27(3):174\u2013181 (Nov)","journal-title":"J Autoimmun"},{"issue":"6","key":"8013_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2007.01.006","volume":"6","author":"N Bizzaro","year":"2007","unstructured":"Bizzaro N (2007) Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev 6(6):325\u2013333 (Jun)","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8013_CR30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.autrev.2005.10.007","volume":"5","author":"B Duan","year":"2006","unstructured":"Duan B, Morel L (2006) Role of B-1a cells in autoimmunity. Autoimmun Rev 5(6):403\u2013408 (Jul)","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8013_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","volume":"29","author":"WW Eaton","year":"2007","unstructured":"Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB (2007) Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29(1):1\u20139 (Aug)","journal-title":"J Autoimmun"},{"issue":"3","key":"8013_CR32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.autrev.2006.10.002","volume":"6","author":"J Furuzawa-Carballeda","year":"2007","unstructured":"Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6(3):169\u2013175 (Jan)","journal-title":"Autoimmun Rev"},{"key":"8013_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2006.12.004","volume":"28","author":"N Gleicher","year":"2007","unstructured":"Gleicher N, Barad D (2007) Gender as risk factor for autoimmune diseases. J Autoimmun 28:1\u20136","journal-title":"J Autoimmun"},{"issue":"4","key":"8013_CR34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.autrev.2006.08.004","volume":"6","author":"G Hernandez-Molina","year":"2007","unstructured":"Hernandez-Molina G, Svyryd Y, Sanchez-Guerrero J, Mutchinick OM (2007) The role of the X chromosome in immunity and autoimmunity. Autoimmun Rev 6(4):218\u2013222 (Mar)","journal-title":"Autoimmun Rev"},{"issue":"5","key":"8013_CR35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.autrev.2006.09.012","volume":"6","author":"B Holvast","year":"2007","unstructured":"Holvast B, Huckriede A, Kallenberg CG, Bijl M (2007) Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 6(5):300\u2013305 (Apr)","journal-title":"Autoimmun Rev"},{"issue":"2\u20133","key":"8013_CR36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2007.02.003","volume":"28","author":"R Rieger","year":"2007","unstructured":"Rieger R, Gershwin ME (2007) The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 28(2\u20133):76\u201384 (Mar\u2013May)","journal-title":"J Autoimmun"},{"issue":"6","key":"8013_CR37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.berh.2006.08.007","volume":"20","author":"R Franssila","year":"2006","unstructured":"Franssila R, Hedman K (2006) Infection and musculoskeletal conditions: Viral causes of arthritis. Best Pract Res Clin Rheumatol 20(6):1139\u20131157 (Dec)","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"8013_CR38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/17402520500285247","volume":"12","author":"DP Bogdanos","year":"2005","unstructured":"Bogdanos DP, Smith H, Ma Y, Baum H, Mieli-Vergani G, Vergani D (2005) A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol 12(3):217\u2013224 (Sep)","journal-title":"Clin Dev Immunol"},{"key":"8013_CR39","first-page":"123","volume-title":"Infection and autoimmunity","author":"AM Denman","year":"2004","unstructured":"Denman AM, Rager-Zisman B (2004) Viruses: the culprits of autoimmune diseases? In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 123\u2013153"},{"key":"8013_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-044451271-0\/50022-3","volume-title":"Infection and autoimmunity","author":"A Achiron","year":"2004","unstructured":"Achiron A (2004) Viruses and multiple sclerosis. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam pp 263\u2013270"},{"key":"8013_CR41","first-page":"515","volume-title":"Infection and autoimmunity","author":"T Yaron","year":"2004","unstructured":"Yaron T, Villanueva R (2004) Infection and autoimmune thyroid diseases. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 515\u2013530"},{"issue":"3","key":"8013_CR42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1440-1746.2003.02982.x","volume":"18","author":"Y Nagao","year":"2003","unstructured":"Nagao Y, Hanada S, Shishido S, Ide T, Kumashiro R, Ueno T et al (2003) Incidence of Sjogren\u2019s syndrome in Japanese patients with hepatitis C virus infection. J Gastroenterol Hepatol 18(3):258\u2013266 (Mar)","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"8013_CR43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/ard.41.5.479","volume":"41","author":"H Permin","year":"1982","unstructured":"Permin H, Aldershvile J, Nielsen JO (1982) Hepatitis B virus infection in patients with rheumatic diseases. Ann Rheum Dis 41(5):479\u2013482 (Oct)","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8013_CR44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-510X(96)00019-6","volume":"139","author":"M Matsui","year":"1996","unstructured":"Matsui M, Kakigi R, Watanabe S, Kuroda Y (1996) Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier. J Neurol Sci 139(2):235\u2013237 (Aug)","journal-title":"J Neurol Sci"},{"issue":"5","key":"8013_CR45","first-page":"366","volume":"13","author":"SS Pierangeli","year":"2006","unstructured":"Pierangeli SS, Chen PP, Gonzalez EB (2006) Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Opin Hematol 13(5):366\u2013375 (Sep)","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"8013_CR46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2362.2003.01110.x","volume":"33","author":"K Zachou","year":"2003","unstructured":"Zachou K, Liaskos C, Christodoulou DK, Kardasi M, Papadamou G, Gatselis N et al (2003) Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Invest 33(2):161\u2013168 (Feb)","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"8013_CR47","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s005350050345","volume":"35","author":"M Harada","year":"2000","unstructured":"Harada M, Fujisawa Y, Sakisaka S, Kawaguchi T, Taniguchi E, Sakamoto M et al (2000) High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 35(4):272\u2013277","journal-title":"J Gastroenterol"},{"key":"8013_CR48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/B978-044452763-9\/50089-5","volume-title":"Autoantibodies","author":"E Matsuura","year":"2007","unstructured":"Matsuura E, Dier KJ, Lopez LR (2007) b2- Glycioriteub I \/autoantibodies. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds) Autoantibodies, 2nd ed. Elsevier, Amsterdam, pp 687\u2013754","edition":"2"},{"issue":"5","key":"8013_CR49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.60.5.500","volume":"6","author":"H Guglielmone","year":"2001","unstructured":"Guglielmone H, Vitozzi S, Elbarcha O, Fernandez E (2001) Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann Rheum Dis 60(5):500\u2013504 (May)","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8013_CR50","first-page":"213","volume":"15","author":"A Kansu","year":"2004","unstructured":"Kansu A, Kuloglu Z, Demirceken F, Girgin N (2004) Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha. Turk J Gastroenterol 15(4):213\u2013218 (Dec)","journal-title":"Turk J Gastroenterol"},{"issue":"5\u20136","key":"8013_CR51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0753-3322(99)80095-X","volume":"53","author":"FL Dumoulin","year":"1999","unstructured":"Dumoulin FL, Leifeld L, Sauerbruch T, Spengler U (1999) Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother 53(5\u20136):242\u2013254 (Jun)","journal-title":"Biomed Pharmacother"},{"key":"8013_CR52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/B978-044451271-0\/50057-0","volume-title":"Infection and autoimmunity","author":"LJ Jara","year":"2004","unstructured":"Jara LJ, Medina G, Vera-Lastra O, Navarro C, Miranda JM (2004) Interaction between Rheumatoid Arthritis and Infections. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 729\u2013740"},{"issue":"25","key":"8013_CR53","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMra040226","volume":"350","author":"JR O\u2019Dell","year":"2004","unstructured":"O\u2019Dell JR (2004) Therapeutic strategies for rheumatoid arthritis. N Engl J Med 350(25):2591\u20132602 (Jun 17)","journal-title":"N Engl J Med"},{"key":"8013_CR54","first-page":"A1","volume":"9","author":"SI Lee","year":"2006","unstructured":"Lee SI, Yoo WH, Yun HJ, Kim DS, Lee HS, Choi SI, et al (2006) Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection. Clin Rheumatol 9:A1\u2013A5 (Nov 29)","journal-title":"Clin Rheumatol"},{"issue":"9561","key":"8013_CR55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(07)60279-7","volume":"369","author":"DP D\u2019Cruz","year":"2007","unstructured":"D\u2019Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet 369(9561):587\u2013596 (Feb 17)","journal-title":"Lancet"},{"issue":"1\u20132","key":"8013_CR56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.0300-9475.2004.01463.x","volume":"60","author":"H Bagavant","year":"2004","unstructured":"Bagavant H, Deshmukh US, Gaskin F, Fu SM (2004) Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. Scand J Immunol 60(1\u20132):52\u201363 (Jul\u2013Aug)","journal-title":"Scand J Immunol"},{"key":"8013_CR57","first-page":"491","volume-title":"Infection and autoimmunity","author":"Y Shoenfeld","year":"2004","unstructured":"Gisele Zandman-Goddard, Shoenfeld Y (2004) SLE and infections. In: Y Shoenfeld, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 491\u2013503"},{"issue":"2","key":"8013_CR58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.1982.tb02711.x","volume":"6","author":"LM Looi","year":"1982","unstructured":"Looi LM, Prathap K (1982) Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus. Histopathology 6(2):141\u2013147 (Mar)","journal-title":"Histopathology"},{"issue":"2","key":"8013_CR59","first-page":"185","volume":"111","author":"KN Lai","year":"1987","unstructured":"Lai KN, Lai FM, Lo S (1987) Leung A Is there a pathogenetic role of hepatitis B virus in lupus nephritis? Arch Pathol Lab Med 111(2):185\u2013188 (Feb)","journal-title":"Arch Pathol Lab Med"},{"issue":"15","key":"8013_CR60","first-page":"842","volume":"286","author":"J Ziegenfuss","year":"1972","unstructured":"Ziegenfuss J, Bergquist E, Burka E (1972) Australia antigen in systemic lupus erythematosus. N Engl J Med 286(15):842\u2013843 (Apr 13)","journal-title":"N Engl J Med"},{"issue":"13","key":"8013_CR61","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJM199809243391306","volume":"339","author":"DE Hricik","year":"1998","unstructured":"Hricik DE, Chung-Park M, Sedor JR (1998) Glomerulonephritis. N Engl J Med 339(13):888\u2013899 (Sep 24)","journal-title":"N Engl J Med"},{"issue":"4","key":"8013_CR62","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ki.1981.55","volume":"19","author":"Q Maggiore","year":"1981","unstructured":"Maggiore Q, Bartolomeo F, L\u2019Abbate A, Misefari V (1981) HBsAg glomerular deposits in glomerulonephritis: fact or artifact? Kidney Int 19(4):579\u2013586 (Apr)","journal-title":"Kidney Int"},{"issue":"240","key":"8013_CR63","first-page":"323","volume":"63","author":"KN Lai","year":"1987","unstructured":"Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Vallance-Owen J (1987) The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med 63(240):323\u2013333 (Apr)","journal-title":"Q J Med"},{"issue":"3","key":"8013_CR64","first-page":"121","volume":"20","author":"HC Hsu","year":"1983","unstructured":"Hsu HC, Lin GH, Chang MH, Chen CH (1983) Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan. Clin Nephrol 20(3):121\u2013129 (Sep)","journal-title":"Clin Nephrol"},{"issue":"1","key":"8013_CR65","first-page":"35","volume":"4","author":"R Mader","year":"1992","unstructured":"Mader R, Keystone EC (1992) Infections that cause vasculitis. Curr Opin Rheumatol 4(1):35\u201338 (Feb)","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"8013_CR66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaut.2004.11.001","volume":"24","author":"Y Chanseaud","year":"2005","unstructured":"Chanseaud Y, Tamby MC, Guilpain P, Reinbolt J, Kambouchner M, Boyer N et al (2005) Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener\u2019s granulomatosis. J Autoimmun 24(2):169\u2013179 (Mar)","journal-title":"J Autoimmun"},{"key":"8013_CR67","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-044451271-0\/50018-1","volume-title":"Infection and autoimmunity","author":"L Guillevin","year":"2004","unstructured":"Guillevin L, Pascal C, Pagnoux C (2004) Virus-induced systemic Vasculitides. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 213\u2013219"},{"issue":"2 Suppl 41","key":"8013_CR68","first-page":"S71","volume":"24","author":"C Pagnoux","year":"2006","unstructured":"Pagnoux C, Cohen P, Guillevin L (2006) Vasculitides secondary to infections. Clin Exp Rheumatol 24(2 Suppl 41):S71\u2013S81 (Mar\u2013Apr)","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"8013_CR69","first-page":"32","volume":"2","author":"ZC Chi","year":"2003","unstructured":"Chi ZC, Ma SZ (2003) Rheumatologic manifestations of hepatic diseases. Hepatobiliary Pancreat Dis Int 2(1):32\u201337 (Feb)","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"8013_CR70","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/B978-044451271-0\/50043-0","volume-title":"Infection and autoimmunity","author":"JWC Tervaert","year":"2004","unstructured":"Tervaert JWC, Stegeman CA (2004) Infections and Vasculitis. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 549\u2013557"},{"issue":"5","key":"8013_CR71","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","volume":"74","author":"L Guillevin","year":"1995","unstructured":"Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O et al (1995) Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74(5):238\u2013253 (Sep)","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"8013_CR72","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.md.0000180792.80212.5e","volume":"84","author":"L Guillevin","year":"2005","unstructured":"Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E et al (2005) Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84(5):313\u2013322 (Sep)","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"8013_CR73","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jcp.27.11.863","volume":"27","author":"CG Trepo","year":"1974","unstructured":"Trepo CG, Zucherman AJ, Bird RC, Prince AM (1974) The role of circulating hepatitis B antigen\/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol 27(11):863\u2013868 (Nov)","journal-title":"J Clin Pathol"},{"issue":"6","key":"8013_CR74","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2169\/internalmedicine.35.468","volume":"35","author":"C Murakami","year":"1996","unstructured":"Murakami C, Hino K, Okazaki M, Fujii K, Okuda M, Hanada H et al (1996) Hepatitis B virus carrier status linked to autoimmune hepatitis. Intern Med 35(6):468\u2013471 (Jun)","journal-title":"Intern Med"},{"issue":"3","key":"8013_CR75","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0168-8278(05)80279-X","volume":"18","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF, Homburger HA (1993) Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol 18(3):342\u2013352 (Jul)","journal-title":"J Hepatol"},{"key":"8013_CR76","first-page":"221","volume-title":"Infection and autoimmunity","author":"F Cainelli","year":"2004","unstructured":"Sandro Vento, Cainelli F (2004) Viral Infections and Autoimmune Hepatitis. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 221\u2013227"},{"issue":"1","key":"8013_CR77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/dmrr.337","volume":"19","author":"HS Jun","year":"2003","unstructured":"Jun HS, Yoon JW (2003) A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 19(1):8\u201331 (Jan\u2013Feb)","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"8013_CR78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diacare.8.3.250","volume":"8","author":"KG Khuri","year":"1985","unstructured":"Khuri KG, Shamma\u2019a MH, Abourizk N (1985) Hepatitis B virus markers in diabetes mellitus. Diabetes Care 8(3):250\u2013253 (May\u2013Jun)","journal-title":"Diabetes Care"},{"issue":"7","key":"8013_CR79","first-page":"CR516","volume":"8","author":"W Halota","year":"2002","unstructured":"Halota W, Muszynska M, Pawlowska M (2002) Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Med Sci Monit 8(7):CR516\u2013CR519 (Jul)","journal-title":"Med Sci Monit"},{"issue":"9","key":"8013_CR80","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.4049\/jimmunol.152.9.4699","volume":"152","author":"DP Singh","year":"1994","unstructured":"Singh DP, Kikuchi T, Singh VK, Shinohara T (1994) A single amino acid substitution in core residues of S-antigen prevents experimental autoimmune uveitis. J Immunol 152(9):4699\u20134705 (May 1)","journal-title":"J Immunol"},{"issue":"3","key":"8013_CR81","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hep.510240309","volume":"24","author":"GV Gregorio","year":"1996","unstructured":"Gregorio GV, Jones H, Choudhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G et al (1996) Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. Hepatology 24(3):520\u2013523 (Sep)","journal-title":"Hepatology"},{"issue":"3","key":"8013_CR82","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.4049\/jimmunol.162.3.1802","volume":"162","author":"GV Gregorio","year":"1999","unstructured":"Gregorio GV, Choudhuri K, Ma Y, Vegnente A, Mieli-Vergani G, Vergani D (1999) Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J Immunol 162(3):1802\u20131810 (Feb 1)","journal-title":"J Immunol"},{"issue":"2","key":"8013_CR83","first-page":"217","volume":"61","author":"D Vergani","year":"1998","unstructured":"Vergani D, Gregorio GV, Choudhuri K, Ma Y, Vegnente A, Mieli-Vergani G (1998) Hepatitis virus induced autoimmunity. Acta Gastroenterol Belg 61(2):217\u2013218 (Apr\u2013Jun)","journal-title":"Acta Gastroenterol Belg"},{"issue":"4","key":"8013_CR84","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/08916930500144484","volume":"38","author":"DA Geier","year":"2005","unstructured":"Geier DA, Geier MR (2005) A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38(4):295\u2013301 (Jun)","journal-title":"Autoimmunity"},{"issue":"1","key":"8013_CR85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2004.11.007","volume":"24","author":"E Piaggio","year":"2005","unstructured":"Piaggio E, Ben Younes A, Desbois S, Gout O, Tourbah A, Lyon-Caen O et al. (2005) Hepatitis B vaccination and central nervous system demyelination: an immunological approach. J Autoimmun 24(1):33\u201337 (Feb)","journal-title":"J Autoimmun"},{"issue":"2","key":"8013_CR86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/08916930400027078","volume":"38","author":"Y Berkun","year":"2005","unstructured":"Berkun Y, Mimouni D, Shoenfeld Y (2005) Pemphigus following hepatitis B vaccination-coincidence or causality? Autoimmunity 38(2):117\u2013179 (Mar)","journal-title":"Autoimmunity"},{"issue":"10","key":"8013_CR87","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/rheumatology\/38.10.978","volume":"38","author":"JF Maillefert","year":"1999","unstructured":"Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B et al (1999) Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) 38(10):978\u2013983 (Oct)","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8013_CR88","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tox.2003.10.005","volume":"196","author":"G Ravel","year":"2004","unstructured":"Ravel G, Christ M, Horand F (2004) Descotes J. Autoimmunity, environmental exposure and vaccination:is there a link? Toxicology 196(3):211\u2013216 (Mar 15)","journal-title":"Toxicology"},{"issue":"2","key":"8013_CR89","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.autrev.2004.10.002","volume":"4","author":"M Girard","year":"2005","unstructured":"Girard M (2005) Autoimmune hazards of hepatitis B vaccine. Autoimmun Rev 4(2):96\u2013100 (Feb)","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8013_CR90","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaut.2006.01.001","volume":"26","author":"JM Anaya","year":"2006","unstructured":"Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H et al (2006) Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 26(3):208\u2013214 (May)","journal-title":"J Autoimmun"},{"issue":"1","key":"8013_CR91","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2006.04.005","volume":"27","author":"J AutoimmunAoki","year":"2006","unstructured":"J AutoimmunAoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, et al (2006) IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27(1):50\u201353 (Aug)","journal-title":"J Autoimmun"},{"issue":"4","key":"8013_CR92","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaut.2007.02.016","volume":"28","author":"Y Ban","year":"2007","unstructured":"Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES et al (2007) The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun 28(4):201\u2013207 (Jun)","journal-title":"J Autoimmun"},{"issue":"4","key":"8013_CR93","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.autrev.2005.07.007","volume":"5","author":"SR Binder","year":"2006","unstructured":"Binder SR, Hixson C, Glossenger J (2006) Protein arrays and pattern recognition: new tools to assist in the identification and management of autoimmune disease. Autoimmun Rev 5(4):234\u2013241 (Apr)","journal-title":"Autoimmun Rev"},{"issue":"4","key":"8013_CR94","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.autrev.2005.09.011","volume":"5","author":"AT Borchers","year":"2006","unstructured":"Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME (2006) Juvenile idiopathic arthritis. Autoimmun Rev 5(4):279\u2013298 (Apr)","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8013_CR95","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.autrev.2006.03.010","volume":"5","author":"D Brandt","year":"2006","unstructured":"Brandt D, Gershwin ME (2006) Common variable immune deficiency and autoimmunity. Autoimmun Rev 5(7):465\u2013470 (Aug)","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8013_CR96","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.autrev.2005.09.006","volume":"5","author":"SD Fleming","year":"2006","unstructured":"Fleming SD, Tsokos GC (2006) Complement, natural antibodies, autoantibodies and tissue injury. Autoimmun Rev 5(2):89\u201392 (Feb)","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8013_CR97","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.autrev.2006.12.005","volume":"6","author":"AL Foreman","year":"2007","unstructured":"Foreman AL, Van de Water J, Gougeon ML, Gershwin ME (2007) B cells in autoimmune diseases: Insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev 6(6):387\u2013401 (Jun)","journal-title":"Autoimmun Rev"},{"issue":"5","key":"8013_CR98","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2006.09.007","volume":"6","author":"L Fry","year":"2007","unstructured":"Fry L, Baker BS, Powles AV (2007) Psoriasis-a possible candidate for vaccination. Autoimmun Rev 6(5):286\u2013289 (Apr)","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8013_CR99","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2005.11.001","volume":"26","author":"P Lapierre","year":"2006","unstructured":"Lapierre P, Beland K, Djilali-Saiah I, Alvarez F (2006) Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development. J Autoimmun 26(2):82\u201389 (Mar)","journal-title":"J Autoimmun"},{"issue":"4","key":"8013_CR100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2006.10.002","volume":"27","author":"BO Nilsson","year":"2006","unstructured":"Nilsson BO, Skogh T, Ernerudh J, Johansson B, Lofgren S, Wikby A et al (2006) Antinuclear antibodies in the oldest-old women and men. J Autoimmun 27(4):281\u2013288 (Dec)","journal-title":"J Autoimmun"},{"issue":"2","key":"8013_CR101","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaut.2006.06.001","volume":"27","author":"N Pontynen","year":"2006","unstructured":"Pontynen N, Miettinen A, Arstila TP, Kampe O, Alimohammadi M, Vaarala O et al (2006) Aire deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients. J Autoimmun 27(2):96\u2013104 (Sep)","journal-title":"J Autoimmun"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8013-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-007-8013-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8013-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T00:46:06Z","timestamp":1684025166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-007-8013-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,18]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["8013"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-8013-6","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,18]]}}}